Company Overview - Sensus Healthcare, Inc. (SRTS) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3] - The company has a Zacks Rank of 2 (Buy), suggesting favorable market performance [4] Performance Metrics - Over the past week, SRTS shares increased by 1.54%, slightly outperforming the Zacks Medical - Instruments industry, which rose by 1.53% [6] - In the last month, SRTS shares rose by 3.36%, significantly better than the industry's performance of 0.98% [6] - For a longer-term perspective, SRTS shares have appreciated by 6.6% over the past quarter and an impressive 107.72% over the last year, compared to the S&P 500's gains of 6.49% and 25.94%, respectively [7] Trading Volume - The average 20-day trading volume for SRTS is 257,456 shares, which serves as a useful indicator of market interest and price movement [8] Earnings Outlook - Recent earnings estimate revisions for SRTS show one upward revision for the full year, increasing the consensus estimate from $0.29 to $0.36 over the past 60 days [10] - For the next fiscal year, there has been one upward revision with no downward revisions during the same period, indicating positive earnings momentum [10]
Sensus Healthcare, Inc. (SRTS) is a Great Momentum Stock: Should You Buy?